BioSpace News Archive

Bio-Techne Corporation announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, and amortization target of $55 million, triggering Bio-Techne’s initial investment in the company, which is expected to close at the end of March 2023.

Evogene Ltd. today announced that it will attend and meeting with investors at the 35th Annual ROTH Conference being held in Dana Point, California on March 13-14, 2023.

Generian Pharmaceuticals, Inc. , today announced that Hank Safferstein , Chief Executive Officer of Generian Pharmaceuticals, will host investor meetings at the Cowen 43rd Annual Healthcare Conference in Boston, MA, on Tuesday, March 7, 2023.

Chemotherapy affects the ability of a patient’s immune system to attack pancreatic tumors, a new study shows.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, March 9, 2023 to report financial results for the year ended December 31, 2022 and discuss recent corporate highlights.

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Harout Semerjian, Chief Executive Officer, will participate in the Leukemia Panel at the Cowen 43rd Annual Health Care Conference in Boston, MA on Wednesday, March 8, 2023 at 12:50 p.m. ET.

Novanta Inc. today reported financial results for the fourth quarter and full year 2022.

GeneDx today announced that company management will participate at the Cowen 43rd Annual Healthcare Conference in Boston, MA.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced its financial results for the fourth quarter and year ended December 31, 2022 and provided a corporate update.

Sequana Medical NV announces positive results from its Phase 1 single-center, single-arm, single-dose trial with its second-generation DSR product.